COVID-19: Maharashtra launches "world's largest" convalescent plasma project
This method involves the transfusion of plasma from a convalescent (recovering) coronavirus patient to a critical patient. The blood of a recovering patient is supposed to be rich in antibodies produced in the body to fight the virus, which are expected to help the critical patient recover.
Maharashtra Chief Minister Uddhav Thackeray on Monday launched convalescent plasma therapy-cum-trial project for treatment of critical COVID-19 patients with a state medical education department official calling it the largest initiative of its kind in the world.
Convalescent plasma therapy, also called passive antibody therapy, seeks to obtain plasma from the blood of people who have recovered from the infection to inject into patients undergoing treatment.
"The project, titled 'Platina', is the largest convalescent plasma therapy-cum-trial project in the world.
With it, we intend to save lives of some 500 critical COVID-19 patients. The trial will be held in 17 medical colleges under the department of medical education and drugs, and four BMC-run colleges in Mumbai," the official said.
All critical patients will receive two doses of 200 ml convalescent plasma free of cost, he added.
Delhi, on the other hand, is set to have a plasma bank set up in two days announced CM Arvind Kejriwal.